Financial statements Pharma Nord
Balance sheet of Pharma Nord
Company age:
Age:
23 y. 10 m. 24 d.
Share capital:
Share capital:
4 000 PLN
Balance sheet data of PHARMA NORD
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 4 237 018,46 | 4 131 565,74 | 4 836 350,96 | 5 205 291,04 | 7 571 115,15 |
| A. Fixed assets | 1 611 752,70 | 1 556 717,34 | 1 576 259,77 | 1 704 024,02 | 1 710 880,06 |
| B. Current assets | 2 625 265,76 | 2 574 848,40 | 3 260 091,19 | 3 501 267,02 | 5 860 235,09 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 237 018,46 | 4 131 565,74 | 4 836 350,96 | 5 205 291,04 | 7 571 115,15 |
| A. Equity | 231 294,22 | 214 137,93 | 222 774,16 | 219 121,79 | 467 963,84 |
| B. Liabilities and provisions for liabilities | 4 005 724,24 | 3 917 427,81 | 4 613 576,80 | 4 986 169,25 | 7 103 151,31 |
| I. Long-term liabilities | 1 638 532,00 | 1 638 532,00 | 1 638 532,00 | 1 638 532,00 | 1 638 532,00 |
| II. Short-term liabilities | 2 268 283,94 | 2 278 895,81 | 2 975 044,80 | 3 347 637,25 | 5 427 207,34 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.